These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11104635)

  • 1. Activity of docetaxel in chemoresistant gestational choriocarcinoma.
    Winquist E; Carey M
    Gynecol Oncol; 2000 Dec; 79(3):523-4. PubMed ID: 11104635
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of choriocarcinoma to paclitaxel. Case report and review of resistance.
    Gerson R; Serrano A; Del Carmen Bello M; Lazaro M; Kudelka AP; Kavanagh JJ
    Eur J Gynaecol Oncol; 1997; 18(2):108-10. PubMed ID: 9105857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible chemotherapeutic response by paclitaxel and other antineoplastic agents in treatment of choriocarcinoma in vitro.
    Farghaly SA
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):1075-7. PubMed ID: 8885780
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel.
    Leahy M; Howell A
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
    Jones WB; Schneider J; Shapiro F; Lewis JL
    Gynecol Oncol; 1996 Apr; 61(1):126-30. PubMed ID: 8626100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel in anthracycline-resistant metastatic breast cancer.
    Hui YF; Ignoffo RJ
    Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxoids: effective agents in anthracycline-resistant breast cancer.
    Ravdin PM
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients resistant to paclitaxel therapy.
    Valero V
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():17-9. PubMed ID: 8862705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel: assessing a range of activity.
    Aapro M; Rowinsky E
    Anticancer Drugs; 2001 Feb; 12 Suppl 1():S1-3. PubMed ID: 11340897
    [No Abstract]   [Full Text] [Related]  

  • 10. Taxanes in hormone-refractory prostate cancer.
    Kang MH; Figg WD; Dahut W
    Cancer Pract; 1999; 7(5):270-2. PubMed ID: 10687598
    [No Abstract]   [Full Text] [Related]  

  • 11. An expanding role for docetaxel.
    Hortobagyi G
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):1-3. PubMed ID: 9865684
    [No Abstract]   [Full Text] [Related]  

  • 12. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxanes in ovarian cancer treatment.
    Seetalarom K; Kudelka AP; Verschraegen CF; Kavanagh JJ
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):14-20. PubMed ID: 9090476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conclusion: the place of docetaxel (Taxotere) in future therapy.
    Khayat D
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():53. PubMed ID: 8862713
    [No Abstract]   [Full Text] [Related]  

  • 15. Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.
    Ravdin PM
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-18-S10-21. PubMed ID: 9275002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Clinical trials with Docetaxel (Taxotere).
    Cheson BD; Arbuck SG; Phillips PH
    Oncology (Williston Park); 1993 Sep; 7(9):51-2. PubMed ID: 8105859
    [No Abstract]   [Full Text] [Related]  

  • 17. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical rationale for developing docetaxel (Taxotere).
    Armand JP
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxoids: a new class of cytotoxic agents.
    Marty M; Extra JM; Giacchetti S; Cuvier C; Espie M
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S25-8. PubMed ID: 7909941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD; Sledge GW
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.